Dr Matthew Frohn
Dr Matthew Frohn graduated from Oxford Brookes University with a BSc Degree in Cell and Molecular Biology followed by a D.Phil in Biochemistry from Oxford University. He worked on research collaborations with Zeneca, and a short research post with a British Biotech subsidiary before joining Oxford Technology Management in 1999. He is currently a partner of Longwall Venture Partners where he is particularly involved with its life science investments. He became a Non-Executive Director of OxSonics™ in November 2013.